Journal of International Psychiatry

Objective To investigate the effect of escitalopram combined with mindfulness cognitive therapy on patients with generalized anxiety disorder and its effect on coping style and self-esteem of patients. Methods Eighty-one patients with generalized anxiety disorder who were treated in our hospital from February 2018 to February 2019 were included in this study. They were divided into two groups by coin-throwing method, and 40 cases of control group received escital For Puland treatment, 41 patients in the observation group were treated with mindfulness cognitive therapy. Both groups were treated continuously for 2 months. Two months later, the Hamilton Anxiety Scale (HAMA) was used to evaluate the anxiety of the two groups, and the self-esteem scale (SES) was used to evaluate. The self-esteem level of the two groups was evaluated by the Simple Coping Style Questionnaire (SCSQ), and the five-factor mindfulness questionnaire (FFMQ) was used to evaluate the level of mindfulness learning. Results After treatment, the HAMA score of the observation group was lower than that of the control group, and the SES score was higher than that of the control group, with a significant difference (P <0.05). The positive response score of the observation group was higher than the control group, and the elimination response score was lower than the control group. Comparison between groups The difference was significant (P <0.05); the scores of FFMQ in the observation group were significantly higher than those in the control group, and the differences were significant (P <0.05); Conclusion Escitalopram combined with mindfulness cognitive therapy can effectively improve the self-esteem of patients with generalized anxiety disorder. Helping patients change their coping styles and improve anxiety symptoms is worthy of clinical recommendation.

escitalopram; mindfulness cognitive therapy; generalized anxiety disorder; coping style; self-esteem